These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 17712237)

  • 1. Long-term effects of methylphenidate transdermal delivery system treatment of ADHD on growth.
    Faraone SV; Giefer EE
    J Am Acad Child Adolesc Psychiatry; 2007 Sep; 46(9):1138-1147. PubMed ID: 17712237
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term tolerability of the methylphenidate transdermal system in pediatric attention-deficit/hyperactivity disorder: a multicenter, prospective, 12-month, open-label, uncontrolled, phase III extension of four clinical trials.
    Findling RL; Wigal SB; Bukstein OG; Boellner SW; Abikoff HB; Turnbow JM; Civil R
    Clin Ther; 2009 Aug; 31(8):1844-55. PubMed ID: 19808143
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of methylphenidate on body index and physical fitness in Korean children with attention deficit hyperactivity disorder.
    Kang KD; Yun SW; Chung U; Kim TH; Park JH; Park IH; Han DH
    Hum Psychopharmacol; 2016 Mar; 31(2):76-82. PubMed ID: 26756111
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A controlled trial of the methylphenidate transdermal system on before-school functioning in children with attention-deficit/hyperactivity disorder.
    Wilens TE; Hammerness P; Martelon M; Brodziak K; Utzinger L; Wong P
    J Clin Psychiatry; 2010 May; 71(5):548-56. PubMed ID: 20492851
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of long-term treatment of methylphenidate on height and weight of school age children with ADHD.
    Zhang H; Du M; Zhuang S
    Neuropediatrics; 2010 Aug; 41(2):55-9. PubMed ID: 20799150
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Methylphenidate transdermal system: In attention-deficit hyperactivity disorder in children.
    Anderson VR; Scott LJ
    Drugs; 2006; 66(8):1117-26. PubMed ID: 16789796
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Single- and multiple-dose pharmacokinetics of methylphenidate administered as methylphenidate transdermal system or osmotic-release oral system methylphenidate to children and adolescents with attention deficit hyperactivity disorder.
    Pierce D; Katic A; Buckwalter M; Webster K
    J Clin Psychopharmacol; 2010 Oct; 30(5):554-64. PubMed ID: 20814325
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Weight, Height, and Body Mass Index in Patients with Attention-Deficit/Hyperactivity Disorder Treated with Methylphenidate.
    Díez-Suárez A; Vallejo-Valdivielso M; Marín-Méndez JJ; de Castro-Manglano P; Soutullo CA
    J Child Adolesc Psychopharmacol; 2017 Oct; 27(8):723-730. PubMed ID: 28817309
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term effects of extended-release mixed amphetamine salts treatment of attention- deficit/hyperactivity disorder on growth.
    Faraone SV; Biederman J; Monuteaux M; Spencer T
    J Child Adolesc Psychopharmacol; 2005 Apr; 15(2):191-202. PubMed ID: 15910204
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HRQL and medication satisfaction in children with ADHD treated with the methylphenidate transdermal system.
    Manos M; Frazier TW; Landgraf JM; Weiss M; Hodgkins P
    Curr Med Res Opin; 2009 Dec; 25(12):3001-10. PubMed ID: 19849639
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A randomized, double-blind, placebo-controlled, laboratory classroom assessment of methylphenidate transdermal system in children with ADHD.
    McGough JJ; Wigal SB; Abikoff H; Turnbow JM; Posner K; Moon E
    J Atten Disord; 2006 Feb; 9(3):476-85. PubMed ID: 16481664
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictors of weight loss in children with attention deficit hyperactivity disorder treated with stimulant medication.
    Schertz M; Adesman AR; Alfieri NE; Bienkowski RS
    Pediatrics; 1996 Oct; 98(4 Pt 1):763-9. PubMed ID: 8885958
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stimulant treatment over 5 years: effects on growth.
    Charach A; Figueroa M; Chen S; Ickowicz A; Schachar R
    J Am Acad Child Adolesc Psychiatry; 2006 Apr; 45(4):415-21. PubMed ID: 16601646
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Time course and predictors of health-related quality of life improvement and medication satisfaction in children diagnosed with attention-deficit/hyperactivity disorder treated with the methylphenidate transdermal system.
    Frazier TW; Weiss M; Hodgkins P; Manos MJ; Landgraf JM; Gibbins C
    J Child Adolesc Psychopharmacol; 2010 Oct; 20(5):355-64. PubMed ID: 20973706
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Practical management of cutaneous reactions to the methylphenidate transdermal system: recommendations from a dermatology expert panel consensus meeting.
    Warshaw EM; Paller AS; Fowler JF; Zirwas MJ
    Clin Ther; 2008 Feb; 30(2):326-37. PubMed ID: 18343271
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Influence of methylphenidate on growth of school age children with attention deficit hyperactivity disorder].
    Zhang HY; Du ML; Zhuang SQ; Liu MN
    Zhonghua Er Ke Za Zhi; 2005 Oct; 43(10):723-7. PubMed ID: 16255846
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Height, weight, IGF-I, IGFBP-3 and thyroid functions in prepubertal children with attention deficit hyperactivity disorder: effect of methylphenidate treatment.
    Bereket A; Turan S; Karaman MG; Haklar G; Ozbay F; Yazgan MY
    Horm Res; 2005; 63(4):159-64. PubMed ID: 15795512
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative effects of methylphenidate and mixed salts amphetamine on height and weight in children with attention-deficit/hyperactivity disorder.
    Pliszka SR; Matthews TL; Braslow KJ; Watson MA
    J Am Acad Child Adolesc Psychiatry; 2006 May; 45(5):520-526. PubMed ID: 16670648
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Does prolonged therapy with a long-acting stimulant suppress growth in children with ADHD?
    Spencer TJ; Faraone SV; Biederman J; Lerner M; Cooper KM; Zimmerman B;
    J Am Acad Child Adolesc Psychiatry; 2006 May; 45(5):527-537. PubMed ID: 16670649
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics of methylphenidate transdermal system (MTS): results from a laboratory classroom study.
    Pierce D; Dixon CM; Wigal SB; McGough JJ
    J Child Adolesc Psychopharmacol; 2008 Aug; 18(4):355-64. PubMed ID: 18759645
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.